ACN Newswire

Tue Jul 14

Eisai: Industry-Academia-Government Joint Development Agreement Aiming for Drug Discovery for Systemic Lupus Erythematosus by Practical Application of Toll-Like Receptor Research Concluded

Written by ACN Newswire

TOKYO, Jul 13, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an industry-academia-government joint research agreement with four universities in Japan concerning the "Industrialization of Japan-originated Toll-like receptor research by Academia-Industry collaborating All-Japan system: Creation of new drug for SLE...

ACN Newswire

Eisai: Industry-Academia-Government Joint Development Agreement Aiming for Drug Discovery for Systemic Lupus Erythematosus by Practical Application of Toll-Like Receptor Research Concluded

Curious Kids: who came up with the first letters?

Thousands of city trees have been lost to development, when we need them more than ever

Scrapping pre-approval of medicine ads will put consumers at risk

Smash Drink Bottles are safe from bacteria

Universities have made progress on responding to sexual assault, but there's more to be done

We're serving up white tea, black tea and #diversity

Greens on track for stability, rather than growth, this election

The 'sports rorts' affair shows the government misunderstands the role of the public service

The real Tinkerbell: don’t mess with these tiny fairy wasps

Carelessly linking crime to being homeless adds to the harmful stigma

Mark Latham in the upper house? A Coalition minority government? The NSW election is nearly upon us and it's going…